期刊文献+

血清Hcy、sCD40L及LDL-C与冠状动脉支架内再狭窄的相关性研究 被引量:11

Postprocedural serum Hcy,sCD40L and LDL-C are associated with coronary in-stent restenosis in patients with drug-coated stent implantation
下载PDF
导出
摘要 目的:探讨血清同型半胱氨酸(Hcy)、LDL-C、可溶性白细胞表面抗原40配体(sCD40L)等因素在冠状动脉支架内再狭窄发生过程中的临床意义。方法:收集冠状动脉药物涂层支架植入术后因胸痛再发/术后6个月常规行冠状动脉造影随访患者共120例,其中88例造影未出现支架内再狭窄(对照组),32例出现再狭窄(再狭窄组),回顾分析两组患者的年龄、性别、高血压病史、糖尿病史、心肌梗死病史及冠心病家族史,收集患者支架植入术后1周以及胸痛再发/术后6个月冠状动脉造影检查这两个时间点的BMI、肾小球滤过率(GFP)、甘油三酯、总胆固醇、糖化血红蛋白(GHbA1c)、LDL-C、HDL-C、Hcy、sCD40L等指标。结果:两组患者在支架植入术后1周各指标比较差异无统计学意义,因胸痛再发/术后6个月行冠状动脉造影随访时发现再狭窄组的LDL-C、Hcy、sCD40L和对照组比较差异有统计学意义(P<0.01),二分类变量Logistic回归分析显示,LDL-C、sCD40L及Hcy的升高会增加再狭窄的风险,且Hcy与LDL-C(r=0.36,P=0.002)、sCD40L(r=0.27,P=0.001)呈正相关。结论:支架植入术后LDL-C、Hcy、sCD40L升高是支架内再狭窄的危险因子,并且Hcy与LDL-C、sCD40L呈正相关。 Objective: To evaluate the roles of serum homocysteine(Hcy),low density lipoprotein cholesterol(LDL-C) and soluble leukocyte surface antigens 40 ligand(sCD40L) in in-stent restenosis(ISR) after successful primary percutaneous coronary intervention(PCI).Methods: Body mass index(BMI),glomerular filtration rate(GFP),total triglycerides(TG),total cholesterol(TC),glycosylated hemoglobin(GHbA1c),LDL-C,high density lipoprotein(HDL-C),Hcy and sCD40L levels were measured in 120 consecutive patients 1 week and 6 months(or chest pain occurred) after PCI.These patients were grouped as ISR and non-ISR based on angiography during follow-up time.Besides,age,sex,hypertension,diabetes mellitus,myocardial infarction family history and coronary heart disease were also compared.Results: There was no significant difference revealed in all parameters between two groups 1 week after PCI.However,6 months after PCI(or chest pain occurred),serum Hcy,sCD40L and LDL-C levels were significantly higher in patients in ISR group than those in non-ISR(P〈0.01).Hcy,sCD40L and LDL-C were significantly correlated with ISR(P〈0.01).Furthermore,Hcy wag positively correlated with LDL-C(r= 0.36,P=0.002) and sCD40L(r=0.27,P=0.001).Conclusion: Hcy,sCD40L and LDL-C are significantly associated with the risk of ISR.Furthermore,Hcy is positively correlated with LDL-C and sCD40L
出处 《新医学》 2012年第1期10-13,共4页 Journal of New Medicine
关键词 同型半胱氨酸 可溶性CD40配体 低密度脂蛋白胆固醇 冠状动脉支架内再狭窄 Homocysteine Soluble leukocyte surface antigens 40 ligand Low-density lipoprotein cholesterol Coronary in-stent restenosis
  • 相关文献

参考文献13

  • 1刘学波,王克强,葛均波.细胞迁移机制在冠状动脉支架再狭窄作用的研究进展[J].心血管病学进展,2004,25(6):436-439. 被引量:8
  • 2Nogami T, Novak M. Soil-Pile interaction in vertical vibration [J]. Earthquake Eng Struct Dyn, 1976, 4 (1): 227-293.
  • 3Novak M, Aboul-Ella F. Impedance functions of pile in layered media[ J ]. Journal of Engineering Mechanics Division, ASCE, 1978, 104 (3):643-661.
  • 4Maragakis E A, Douglas B M, Abdel-Ghaffr S M. An equivalent linear finite element approach for the estimation of pile foundation stiffnesses [J].Earthquake Eng Struct Dyn, 1994, 23:1115-1124.
  • 5ANGULO P. Nonalcoholic fatty liver disease [ J ]. N Engl J Med, 2002, 346 (16) : 1221-1231.
  • 6林东,袁璧钗,黄晓新.血浆同型半胱氨酸水平与脑梗死的临床相关性研究[J].新医学,2010,41(5):305-306. 被引量:14
  • 7JAKUBOWSKI H. The determination of homocysteine- thiolactone in biological samples [ J ]. Anal Biochem, 2002, 308 (1): 112-119.
  • 8蒋晖,李锦,毛建斌,陈茂,范忠才,黄德嘉.同型半胱氨酸对内皮细胞CD40表达的影响[J].心脏杂志,2004,16(5):431-434. 被引量:11
  • 9LIEVENS D, EIJGELAAR ,W J, BIESSEN E A, et al. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis [ J ]. Thromb Haemost, 2009, 102 (2) : 206-214.
  • 10TURKER S, GUNERI S, AKDWNIZ B, et al. Useful- ness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in pa- tients with stable coronary artery disease [ J ]. Am J Car- diol, 2006, 97 (2): 198-202.

二级参考文献80

  • 1Hua-feiDENG YanXIONG.Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta[J].Acta Pharmacologica Sinica,2005,26(1):92-98. 被引量:7
  • 2朱军慧,陈君柱,王兴祥,朱建华,尚云鹏,郭晓纲,戴禾敏.氧化低密度脂蛋白对外周血内皮祖细胞数量和功能的影响[J].中华内分泌代谢杂志,2005,21(1):13-17. 被引量:13
  • 3宓宝斌,刘江华,文格波.氧化低密度脂蛋白对内皮细胞损伤机制的研究进展[J].医学临床研究,2005,22(9):1322-1324. 被引量:8
  • 4Mitra AK, Agrawal DK. In stent restenosis : bane of the stent era. J Clin Pathol, 2006,59:232-239.
  • 5Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke, 2006, 37 : 1923 -1932.
  • 6Pamukeu B, Oflaz H, Nisanei Y. The role of platelet glyeoprotein Ⅲ a polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Am Heart J, 2005 ,149:675-680.
  • 7Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart, 1999,82 : 265 -268.
  • 8Kim E J, Rha SW, Wani SP, et al. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management? Int J Cardiol, 2007, 120:417-419.
  • 9Wilson PW. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med, 2008,121 : S15-S20.
  • 10Bonnet J, McPherson R, Tedgui A, et al. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects ) study. Clin Ther, 2008,30:2298-2313.

共引文献62

同被引文献105

引证文献11

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部